Abstract:On the basis of the structures and activities of our previously identified non-nucleoside reverse transcriptase inhibitors (NNRTIs), we designed and synthesized two sets of derivatives, diarylpyridines (A) and diarylanilines (B), and tested their anti-HIV-1 activity against infection by HIV-1 NL4-3 and IIIB in TZM-bl and MT-2 cells, respectively. The results showed that most compounds exhibited potent anti-HIV-1 activity with low nanomolar EC50 values, and some of them, such as 13m, 14c, and 14e, displayed high potency with subnanomolar EC50 values, which were more potent than etravirine (TMC125, 1) in the same assays. Notably, these compounds were also highly effective against infection by multi-RTI-resistant strains, suggesting a high potential to further develop these compounds as a novel class of NNRTIs with improved antiviral efficacy and resistance profile.

Design, Synthesis and Biological Evaluations of Novel Oxindoles As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1.

Design, Synthesis, and Biological Evaluations of Novel Quinolones As HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors.

ChemInform Abstract: Structure‐Based Design, Synthesis and Biological Evaluation of New N‐Carboxyphenylpyrrole Derivatives as HIV Fusion Inhibitors Targeting gp41.

ChemInform Abstract: Design, Synthesis and Anti‐hiv Integrase Evaluation of 1,2,3‐triazol‐4‐yl‐substituted 1,4‐dihydro‐4‐oxo‐1,5‐naphthyridine‐3‐carboxylic Acids.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of 2‐(4‐(naphthalen‐2‐yl)‐1,2,3‐thiadiazol‐5‐ylthio)‐n‐acetamides As Novel Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors.

ChemInform Abstract: Synthesis and Anti‐hiv Activity Evaluation of Novel 2,4‐disubstituted 7‐Methyl‐1,1,3‐trioxo‐2,4‐dihydro‐pyrazolo[4,5‐e][1,2]thiadiazines.

Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 7. Synthesis, Antiviral Activity, and 3D‐QSAR Investigations of Novel 6‐(1‐naphthoyl) HEPT Analogues.

ChemInform Abstract: Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors. Part 11. Structural Modulations of Diaryltriazines with Potent Anti‐hiv Activity.

ChemInform Abstract: Synthesis and HIV‐1 Integrase Inhibition Activity of Some N‐Arylindoles.

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives As Non‐Peptide Human Immunodeficiency Virus Protease Inhibitors.

ChemInform Abstract: Design, Synthesis and Biological Activities of Novel 1,2,3‐thiadiazole Derivatives Containing Oxime Ether.

ChemInform Abstract: Anti-Human Immunodeficiency Virus-1 (HIV-1) Agents. Part 3. Synthesis and in Vitro Anti-Hiv-1 Activity of Some N-Arylsulfonylindoles.

ChemInform Abstract: Novel 2,4,5‐trisubstituted Oxazole Derivatives: Synthesis and Antiproliferative Activity.

Design, Synthesis, and Preliminary Biological Evaluation of 2,3-Dihydro-3-hydroxymethyl-1,4-benzoxazine Derivatives.

Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines As Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.

Synthesis of 1‐(alkoxymethyl)‐5‐benzyl‐6‐methyluracil As Potential Nonnucleoside HIV‐1 RT Inhibitors.

Regioselective Synthesis of the Novel N4‐Substituted Pyrazolo[4,5‐e][1,2,4]thiadiazines As Potent HIV‐1 NNRTIs.

Synthesis and Biological Evaluation of Novel Quinoxalinone-Based HIV-1 Reverse Transcriptase Inhibitors

ChemInform Abstract: Synthesis and Evaluation of A‐seco Type Triterpenoids for Anti‐hiv‐1 Protease Activity.

ChemInform Abstract: Novel 4h‐1,3,4‐oxadiazin‐5(6h)‐ones with Hydrophobic and Long Alkyl Chains: Design, Synthesis, and Bioactive Diversity on Inhibition of Monoamine Oxidase, Chitin Biosynthesis and Tumor Cell.